1. Home
  2. Analysis
  3. Biotin
  4. Midazolam

Biotin and Midazolam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Biotin (biotin) and Midazolam (midazolam). Common drug interactions include premature labour among females and haemodynamic instability among males.

The phase IV clinical study analyzes what interactions people have when they take Biotin and Midazolam. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Biotin?

Biotin has active ingredients of biotin. It is often used in hair loss. eHealthMe is studying from 35,393 Biotin users. Check the latest studies of Biotin.

What is Midazolam?

Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.

On Jul, 19, 2026

19 people who take Biotin and Midazolam together, and have interactions are studied.

Biotin and Midazolam drug interactions.

What are the common drug interactions of Biotin and Midazolam, by gender? *:

female:

  1. Premature labour
  2. Maternal exposure during pregnancy (use of substance during pregnancy)
  3. Drug ineffective
  4. Premature delivery
  5. Multiple-drug resistance
  6. Normal newborn

male:

  1. Haemodynamic instability (disturbances in the blood movement in our body)
  2. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)
  3. Diarrhoea
  4. Gaze palsy (disorders affecting the ability to move both eyes in the same direction)
  5. Vomiting

What are the common drug interactions of Biotin and Midazolam, by age (0-1 to 60+)? *:

0-1:

  1. Gaze palsy (disorders affecting the ability to move both eyes in the same direction)

2-9:

  1. Left ventricular hypertrophy (the thickening of the myocardium (muscle) of the left ventricle of the heart)

10-19:

n/a

20-29:

n/a

30-39:

  1. Maternal exposure during pregnancy (use of substance during pregnancy)
  2. Drug ineffective
  3. Premature delivery
  4. Multiple-drug resistance
  5. Normal newborn
  6. Premature labour

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 8 people, 42.11%
  2. Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 7 people, 36.84%
  3. Sedation: 2 people, 10.53%
  4. Cortical Dysplasia (neurons in an area of the brain failed to migrate in the proper formation): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Biotin and Midazolam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Biotin and Midazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Biotin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Midazolam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Biotin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Midazolam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on biotin and midazolam (the active ingredients of Biotin and Midazolam, respectively), and Biotin and Midazolam (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.